Format

Send to

Choose Destination
See comment in PubMed Commons below
Antimicrob Agents Chemother. 1993 Jun;37(6):1329-33.

Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.

Author information

  • 1Anti-Infective Research Division, Abbott Laboratories, Abbott Park, Illinois 60064-3500.

Abstract

Clarithromycin provided effective therapy against arthritis induced by Borrelia burgdorferi infection in the hamster. In vitro, clarithromycin was at least 1 log more potent than tetracycline against two isolates of B. burgdorferi from human sources, as measured by MICs and 50% inhibitory concentrations. Clarithromycin was effective in preventing the onset of B. burgdorferi-induced arthritis, as determined by several parameters of paw swelling. When administered after the onset of arthritis, clarithromycin therapy reduced the degree of swelling and decreased recovery time. These results suggest that clarithromycin has potential as an effective therapy for Lyme disease.

PMID:
8328782
PMCID:
PMC187961
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center